We were privileged to have been granted a moment — a memory — with one of the finest writers of our times, a man whose ...

Cissy Houston had Alzheimer's disease, according to a statement from Quinn ... In an era in the 1970s where stand-up comedy ...

"I am honored to join C-Path and to lead the CPAD Consortium in its mission to drive therapeutic innovation for Alzheimer's disease," said Dr. Tatton. "There is so much momentum in AD research today, ...

In healthy brains, immune cells called microglia patrol for damage, clearing away debris and harmful proteins. But in the presence of the APOE4 protein-;the most important genetic risk factor for ...

The only approved treatments for Alzheimer’s disease are medications with limited effectiveness and a risk of severe, sometimes deadly, side effects. That’s why scientists search for therapies ...

MALVERN, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) ('Annovis' or the 'Company'), a late-stage clinical ...

Critical Path Institute today announced key leadership appointments: Diane Stephenson, Ph.D., has been promoted to Vice President of Neurology, and Nadine Tatton, Ph.D., has been welcomed as the new ...

Roche may seek an accelerated U.S. approval of its experimental Alzheimer’s disease drug trontinemab ... precedent to seek an abbreviated approval path, as the company plans to look for an ...

Annovis Bio (ANVS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ram Selvaraju ...

led by Founder, President and CEO Dr. Maria Maccecchini, shares exciting developments regarding its pioneering Alzheimer's and Parkinson's drug candidate, buntanetap. In her interview on IBN's ...

This view of Alzheimer's as a circuit disorder that ultimately disrupts cognition is speculative, Lein stressed. But the new study's cellular mapping supports reframing Alzheimer's beyond just a ...

Alzheimer disease (AD) is the sixth leading cause of death in the United States and is projected to affect over 13 million people by the year 2060. Although there is currently no cure for AD, ...